Parathyroid hormone oxidation in chronic kidney disease: clinical relevance?
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 33892858.
- Also identified by DOI 10.1016/j.kint.2021.01.019.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In chronic kidney disease, parathyroid hormone (PTH), like all proteins, can undergo post-translational modifications, including oxidation. This can lead to structural and functional changes of the hormone. It has been hypothesized that currently used PTH measurement methods do not adequately reflect PTH-related bone and cardiovascular abnormalities in chronic kidney disease owing to the presence of oxidized, biologically inactive PTH in the circulation. Ursem et al. now report a strong correlation between serum non-oxidized and total PTH, and comparable associations with histomorphometric and circulating bone turnover markers, pleading against this hypothesis.
Medical subject headings
- Parathyroid Hormone
- Renal Insufficiency, Chronic